Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

The era of fast, cheap genome sequencing is here Illumina just announced a machine that can crack genomes twice as fast.

Illumina introduced gene-sequencing machines that it says can more-than-double capacity and slash the cost of sequencing, as it faces competition and price pressures.

DNA sequencing machines have typically been designated for “research use only,” but are increasingly used in medical settings to help diagnose disease.

San Diego-based genomics pioneer Illumina on Thursday introduced a new machine that will sequence a human genome in half a day for just $200.

Illumina DNA sequencing machines are vulnerable to exploitation. Both the Cybersecurity and Infrastructure Security Agency (CISA) and the Food and Drug Administration (FDA) have published ...

Gene sequencing machine maker Illumina on Tuesday forecast 2024 sales from its core segment to decline, a sign that subdued demand for its instruments used in genetic tests could extend further ...

Illumina is by far the dominant supplier of sequencing machines to research labs, hospitals and pharmaceutical companies, with a market share of over 75% in the U.S.

Genetic sequencing company Illumina has unveiled a new machine it says can sequence the human genome for just $200, Wired reported Sept. 29.

Illumina’s sequencers use a method called “sequencing by synthesis” to decipher DNA. This process first requires that DNA strands, which are usually in double-helix form, be split into ...